Literature DB >> 18372337

Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production.

Johan Jendholm1, Martin Samuelsson, Lars-Olaf Cardell, Arne Forsgren, Kristian Riesbeck.   

Abstract

The respiratory pathogen Moraxella catarrhalis has a high affinity for human IgD and is mitogenic for peripheral blood B lymphocytes. Moraxella IgD-binding protein, which is a multifunctional outer membrane protein with adhesive properties, is responsible for the interaction. Previous experiments with the Ig-binding B cell superantigens protein A and protein L from Staphylococcus aureus and Peptostreptococcus magnus, respectively, have suggested that nonimmune BCR cross-linking induces B cell apoptosis through the intrinsic pathway. The goal of this study was to characterize early and late B cell events in the presence of M. catarrhalis in comparison with S. aureus. Despite an increased phosphatidyl serine translocation as revealed by Annexin V binding in flow cytometry analyses, neither M. catarrhalis nor S. aureus induced activation-associated apoptotic cell death in purified human tonsillar B cells. In contrast, a vigorous B cell proliferation, as quantified using thymidine incorporation and CFSE staining, was observed. An increased expression of an array of surface proteins (i.e., CD19, CD21, CD40, CD45, CD54, CD69, CD86, CD95, and HLA-DR) and IgM production was found upon activation with M. catarrhalis. In conclusion, M. catarrhalis-dependent B cell activation does not result in apoptosis but in cell division and nonspecific IgM synthesis, suggesting that the bacterial interaction with tonsillar B cells serves to redirect the early adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372337     DOI: 10.1189/jlb.1107788

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  A fusion protein derived from Moraxella catarrhalis and Neisseria meningitidis aimed for immune modulation of human B cells.

Authors:  Oindrilla Mukherjee; Birendra Singh; Burcu Bayrak; Ann-Beth Jonsson; Matthias Mörgelin; Kristian Riesbeck
Journal:  Hum Vaccin Immunother       Date:  2015-06-04       Impact factor: 3.452

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

3.  Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis.

Authors:  Jin-Young Min; Jayakar V Nayak; Kathryn E Hulse; Whitney W Stevens; Paul A Raju; Julia H Huang; Lydia A Suh; Griet A Van Roey; James E Norton; Roderick G Carter; Caroline P E Price; Ava R Weibman; Ali R Rashan; Eliver E Ghosn; Zara M Patel; Tetsuya Homma; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Atsushi Kato; Peter H Hwang; Robert C Kern; Leonore A Herzenberg; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2017-06-16       Impact factor: 10.793

4.  Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection.

Authors:  Stephanie Planque; Maria Salas; Yukie Mitsuda; Marcin Sienczyk; Miguel A Escobar; Jason P Mooney; Mary-Kate Morris; Yasuhiro Nishiyama; Dipanjan Ghosh; Amit Kumar; Feng Gao; Carl V Hanson; Sudhir Paul
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

5.  KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.

Authors:  Lynn M Hassman; Thomas J Ellison; Dean H Kedes
Journal:  J Clin Invest       Date:  2011-01-18       Impact factor: 14.808

6.  Expression of immunoglobulin D is increased in chronic rhinosinusitis.

Authors:  Mofiyinfolu Sokoya; Vijay R Ramakrishnan; Daniel N Frank; Jeremy Rahkola; Anne Getz; Todd T Kingdom; Jennifer M Kofonow; Quyen Nguyen; Edward N Janoff
Journal:  Ann Allergy Asthma Immunol       Date:  2017-10       Impact factor: 6.347

Review 7.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

8.  Bacterial lectin BambL acts as a B cell superantigen.

Authors:  Marco Frensch; Christina Jäger; Peter F Müller; Annamaria Tadić; Isabel Wilhelm; Sarah Wehrum; Britta Diedrich; Beate Fischer; Ana Valeria Meléndez; Joern Dengjel; Hermann Eibel; Winfried Römer
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

9.  B cell activation by outer membrane vesicles--a novel virulence mechanism.

Authors:  Maria Laura A Perez Vidakovics; Johan Jendholm; Matthias Mörgelin; Anne Månsson; Christer Larsson; Lars-Olaf Cardell; Kristian Riesbeck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.